A new study confirms:
Testosterone Replacement Therapy is safe!
You have probably heard that Testosterone Replacement Therapy (TRT) is risky for older men. Many law firms have run advertisements along the line of this:
Attention men! If you were prescribed testosterone therapy and later suffered a heart attack or stroke, this message is for you! Many research studies have determined that prescription testosterone increases the risk of heart attacks and strokes. If you have used any type of testosterone, such as pellets, gels, or injections, and then suffered a stroke or heart attack, call the law firm of XXXXXXX at (XXX)-XXX-XXXX. The manufacturer may be liable, and you may be entitled to substantial compensation. CALL NOW and get the compensation you deserve!
How about the Food and Drug Administration (FDA) warnings on testosterone packages: “Reported serious adverse outcomes include heart attack, heart failure, stroke, depression, hostility, aggression, liver toxicity, and male infertility.” That sounds pretty serious.
But is it true that testosterone is a killer in disguise? A wolf in sheep’s clothing? A precursor to deadly, debilitating heart attacks and strokes?
Or is this merely fear-mongering from ambulance-chasing attorneys looking for a quick payday and over-zealous, unelected government bureaucrats that take joy in exercising God-like power over all aspects of our lives?
To answer those questions, we need to put emotion and hyperbole aside, look at the facts and conclusions of recent research, and see what the science says.
A recent study by researchers at the University of Aberdeen in the United Kingdom searched publication databases through August 2018 for randomized controlled trials among patients with testosterone levels of 12 nmol/L or less who had been on TRT for at least 3 months. The mean TRT duration for all study participants was 9.5 months.
The goal of this study was to “provide the most extensive individual participant dataset (IPD) of testosterone trials available, to analyze subtypes of all cardiovascular events observed during treatment, and to investigate the effect of incorporating data from trials that did not provide IPD” said Jemma Hudson, one of the leading researchers of the 37-member team.
The study was extensive, as Hudson promised. The team initially looked at 9,871 studies. After omitting irrelevant studies and duplicates, 225 studies were left. The team then further narrowed the studies to 35. The number of subjects was 5,601 men with a mean age of 65, and the mean Body Mass Index (BMI, a calculated number of pounds divided by height to measure obesity) was 35, which means that some of the men were a bit rotund. Several of them were diabetic, and others had experienced cardiovascular disease.
After rigorously delving through the data, the team's conclusion was clear: They found no evidence that TRT increased the risk of short-term to the medium-term risk of heart attack or stroke in men treated with testosterone for low testosterone (aka “Low-T).
Here are the specifics of the study’s findings:
- No significant elevation of blood pressure, glucose sensitivity, or A1C (a measure of average blood sugar over the previous three months) between the groups.
- Both serum total cholesterol and triglycerides were significantly lower in the testosterone groups.
- The cardiovascular and cerebrovascular (lower brain blood flow) data found that the testosterone subjects reported slightly more (120) deaths than the placebo group (110), but not of statistical significance. Later sensitivity analyses (examining how changes in methods, models, or values of unmeasured variables affected results) found that the risk of cardiovascular or cardio cerebral events was lower after testosterone levels were normalized.
- The testosterone group reported fewer deaths from all causes than the placebo group but, again, not of statistical significance.
- Hemoglobin and hematocrit were higher in the testosterone groups, and the number was statistically relevant. This is not surprising since TRT squelches hepcidin, a hormone produced by the liver that regulates iron levels, and iron levels directly impact red blood cell production. However, only 5 cases of deep-vein thrombosis occurred in the testosterone groups, compared to 7 in the placebo group.
- Most importantly, there was no difference in the groups concerning the development of prostate cancer.
The team weighs in on the results of the study.
Here is the research group statement: "The most frequently recorded cardiovascular event categories in the identified trials were arrhythmia, coronary heart disease, heart failure, cerebrovascular events, and myocardial infarction. We have also identified and reported frequencies of stable angina, peripheral vascular disease, aortic aneurysm, and aortic dissection, which have not been reported by any previous meta-analysis. None of the cardiovascular event subtypes were significantly more common in patients assigned to testosterone treatment than in patients assigned to placebo.”
“We have conducted the most comprehensive study to date investigating the safety of testosterone treatment of hypogonadism. Testosterone treatment did not increase cardiovascular event risk in the short term to medium term.”
These findings were published in The Lancet Healthy Longevity.
This study was one of the most comprehensive examinations of the effects of TRT. The results speak loudly: When undertaken with proper medical supervision, a Testosterone Replacement Therapy treatment regimen can deliver the benefits it promises.
Contrary to the hysterical warnings about TRT causing heart attacks and strokes, testosterone may exhibit “reverse causality” by lowering the risk of cardiovascular events instead of raising them!
More critical, TRT is safe! Notice the last sentence in the final statement of the team: “...Testosterone treatment did not increase cardiovascular event risk in the short term to medium term.”
Contact us for a FREE, no-obligation of the incredible benefits of Testosterone Replacement Therapy (TRT)!
Hudson J, Cruickshank M, Quinton R, et al. Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis. Lancet Healthy Longev. Published online June 1, 2022. doi:10.1016/S2666-7568(22)00096-4
Contact Us Today For A Free Consultation
Once you have completing the above contact form, for security purposes and confirmation, please confirm your information by calling us.
Please call now: 1-800-380-5339.
Welcoming You To Our Clinic, Professor Tom Henderson.
- Get Tested for Hormone Levels, even if You Have No Symptoms - March 17th, 2023
- The Skinny on How Hormones Affect Your Weight - February 19th, 2023
- Nine Hormones that Can Impact Your Weight and How to Promote Hormone Balance - January 26th, 2023
- HGH Therapy – How Can I Know Who Is Legitimate? - January 10th, 2023
- The many health benefits of black tea - December 13th, 2022
- Testosterone Blockers Thwart Melanoma - December 11th, 2022
- Looking to lose weight? Add this ingredient to meals - December 7th, 2022
- Is it possible to live to 180? Perhaps! - November 29th, 2022
- Jeff Bezos Wants to Stop Aging! - November 24th, 2022
- The Quest for the Secret of Longevity - November 24th, 2022
- Matching Sex Drives Are Important to a Healthy Relationship - November 23rd, 2022
- Minoxidil: A potential cure for baldness? - November 16th, 2022
- A former Mr. Olympia speaks about testosterone - November 8th, 2022
- MOTS-c Peptide for Weight Loss and Muscle Building - November 7th, 2022
- A new study reveals that Testosterone improves body composition in men with low testosterone! - October 17th, 2022
- Phoenix Testosterone and HGH - October 14th, 2022
- Toxic Chemicals are Killing your testosterone…And your Manhood! - October 10th, 2022
- Testosterone May Help You Keep Your Job (Or Find Another) - October 4th, 2022
- San Diego Testosterone and HGH - September 23rd, 2022
- San Antonio Testosterone and HGH - September 16th, 2022
- Improving Memory for Diabetics with Testosterone - September 8th, 2022
- Low testosterone in men might increase the risk of severe COVID - September 6th, 2022
- Houston Testosterone and HGH - August 17th, 2022
- Chicago Testosterone and HGH - August 9th, 2022
- Los Angeles Testosterone and Growth Hormone - August 4th, 2022
- Testosterone and Pulsed Electromagnetic Fields (PEMFs) - August 2nd, 2022
- The link between water, HGH, and Testosterone - July 28th, 2022
- New York City Testosterone and HGH - July 27th, 2022
- HGH, Nutrition, Fasting, and Stem Cells…The Fascinating Links! - July 20th, 2022
- How to Boost Testosterone with Food - July 11th, 2022
- Thinking about Testosterone Replacement Therapy (TRT)? - July 5th, 2022
- You Don’t Need Permission to See a Specialist - June 28th, 2022
- Interested in boosting your testosterone levels? Here’s How! - June 22nd, 2022
- Wyoming Testosterone and HGH - May 25th, 2022
- West Virginia HGH Clinics - May 6th, 2022
- Pot Bellies Are Bad for Your Health - Hormone Balance for Men - February 16th, 2022
- Washington, D.C. HGH Clinics - January 18th, 2022
- Zomacton Injections for Hypopituitarism and HGH Deficiency - January 5th, 2022
- Chronic Stress Can Lead to Hair Loss — New Research Reveals How - January 5th, 2022
- Light Therapy: The Incredible Benefits of Red Light Therapy - January 3rd, 2022
- Vermont HGH Clinics - December 27th, 2021
- Utah HGH Clinics - December 17th, 2021
- Finally! A safe, effective oral testosterone pill: Jatenzo! - December 13th, 2021
- South Dakota HGH Clinics - December 9th, 2021
- Rhode Island HGH Clinics - December 3rd, 2021
- North Dakota HGH Clinics - November 26th, 2021
- Testosterone and Food: What you eat can boost your testosterone levels! - November 21st, 2021
- New Mexico HGH Clinics - November 17th, 2021
- Growth Hormone and DHEA - November 14th, 2021
- New Hampshire HGH Clinics - November 11th, 2021
- Testosterone and Liver Health - November 5th, 2021
- Nevada HGH Clinics - November 3rd, 2021
- Growth Hormone, Ghrelin, and Memory - October 15th, 2021
- Growth Hormone, Ghrelin and Leptin - October 15th, 2021
- Nebraska HGH Clinics - October 6th, 2021
- Essential Amino Acids Critical to Health and Hormone Balance - October 6th, 2021
- Montana HGH Clinics - October 1st, 2021
- Boost testosterone by eating more fat! - September 28th, 2021
- Testosterone Replacement Therapy: The secret weapon for controlling Erectile Dysfunction and Sleep Apnea - September 23rd, 2021
- Celebrity Dax Shepard Takes Pride in Results from Testosterone Therapy - September 9th, 2021
- Ipamorelin Acetate – Boosting HGH with Peptides - August 10th, 2021
- Kansas HGH Clinics - August 5th, 2021
- Tesamorelin: the answer to losing those stubborn pounds of fat! - August 2nd, 2021
- Maine HGH Clinics - July 28th, 2021
- What Happens When I Get Growth Hormone Injections? - July 26th, 2021
- Recent Research Concludes: Testosterone Replacement Therapy Lowers Heart Attack Risk - July 21st, 2021
- The Fascinating link between COVID-19 and Testosterone - July 16th, 2021
- Hawaii HGH Clinics - July 14th, 2021
- Delaware HGH Clinics - July 8th, 2021
- The Incredible Longevity benefits of Quercetin - July 6th, 2021
- The Incredible, Health-Boosting Benefits of Mushrooms - June 30th, 2021
- Arkansas HGH Clinics - June 28th, 2021
- Recognizing the Signs of Hormone Imbalance in Men - June 25th, 2021
- Alaska HGH Clinics - June 22nd, 2021
- The benefits of Berberine - June 13th, 2021
- The incredible, awesome health benefits of Onions - June 7th, 2021
- Using Sleep to Amplify Human Growth Hormone - May 27th, 2021
- Melatonin – The Importance of the Sleep Hormone - May 13th, 2021
- Omnitrope Injections for the Treatment of HGH Deficiency - May 6th, 2021
- The Medical Perspective on Inflammation Myths - April 29th, 2021